Usability features for integrated insulin delivery system

US11213622B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11213622-B2
Application numberUS-201916560497-A
CountryUS
Kind codeB2
Filing dateSep 4, 2019
Priority dateMay 22, 2009
Publication dateJan 4, 2022
Grant dateJan 4, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has crossed the analyte threshold.

First claim

Opening claim text (preview).

What is claimed is: 1. A method comprising: detecting an analyte level of a user using an analyte sensor; and delaying an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold. 2. The method of claim 1 , wherein the analyte threshold is a low analyte threshold. 3. The method of claim 1 , wherein the analyte level is a glucose level. 4. The method of claim 3 , wherein the analyte level is an interstitial glucose level. 5. The method of claim 1 , further comprising sounding an alarm after the delay. 6. The method of claim 5 , wherein sounding the alarm after the delay is performed by an electronic device in communication with the analyte sensor. 7. The method of claim 6 , wherein the electronic device comprises a display for user input and output communication. 8. The method of claim 1 , wherein the electronic device is further configured to recommend medication based on the analyte level. 9. The method of claim 1 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold. 10. An analyte monitoring system comprising: an analyte sensor configured for detecting an analyte level of a user; a processor operably coupled to the analyte sensor; and a memory operably coupled to the processor, wherein the memory includes instructions stored therein that, when executed by the processor, cause the processor to: detect the analyte level using the analyte sensor; and delay an annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein an amount of the delay is based on a duration of time in which the analyte level has not exceeded the analyte threshold. 11. The system of claim 10 , wherein the analyte threshold is a low analyte threshold. 12. The system of claim 10 , wherein the analyte level is a glucose level. 13. The system of claim 12 , wherein the analyte level is an interstitial glucose level. 14. The system of claim 10 , further comprising sounding an alarm after the delay. 15. The system of claim 14 , wherein the electronic device comprises a display for user input and output communication. 16. The system of claim 14 , wherein the electronic device is further configured to recommend medication based on the analyte level. 17. The system of claim 14 , wherein the electronic device is further in communication with a medication delivery device. 18. The system of claim 10 , wherein the duration of time corresponds to a duration the analyte level was in a euglycemic range prior to exceeding the analyte threshold.

Assignees

Inventors

Classifications

  • A61M5/1723Primary

    using feedback of body parameters, e.g. blood-sugar, pressure (measurement of body parameters A61B5/00) · CPC title

  • worn on the body to detect health condition by physiological monitoring, e.g. electrocardiogram, temperature, breathing (detecting, measuring or recording for diagnostic purposes A61B5/00) · CPC title

  • Pressure infusion, e.g. using pumps · CPC title

  • for remote operation · CPC title

  • Alarms related to a physiological condition, e.g. details of setting alarm thresholds or avoiding false alarms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11213622B2 cover?
Methods and systems for delaying alarms that include detecting an analyte level using an analyte sensor; and delaying the annunciation of an analyte alarm after the analyte level crosses an analyte threshold, wherein the delay is based on one or both of (1) a magnitude of difference between the analyte level and the analyte threshold and (2) a duration of time in which the analyte level has cro…
Who is the assignee on this patent?
Abbott Diabetes Care Inc
What technology area does this patent fall under?
Primary CPC classification A61M5/1723. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).